The Position of Drospirenone in Premenstrual Syndrome Teratment
Authors:
M. Havlín
Authors‘ workplace:
ADC Sanatorium, Praha, vedoucí MUDr. P. Lippert
Published in:
Ceska Gynekol 2006; 71(1): 70-73
Category:
Original Article
Overview
Objective:
To evaluate influence of hormonal contraceptive drospirenone on premenstrual syndrome (PMS).
Design:
Overall summary of literature.
Author affiliation:
ADC Sanatorium, Praha.
Methods:
Review of scientific studies and publications.
Conclusions:
The author submitted current opinions on premenstrual syndrome, its classification, and treatment. The role of renin – aldosterone system in the genesis of PMS was described. Basic pharmacological characteristics of the remedy containing in one pill 30 mg of Ethinyl Estradiol (EE) and 3 mg of drospirenone are presented. Its therapeutic effects on somatic and psychological PMS symptoms are discussed.
Key words:
premenstrual syndrome – body weight – oedema – drospirenone.
Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineArticle was published in
Czech Gynaecology
2006 Issue 1
Most read in this issue
- Prematurity and Methods of its Screening
- Intraductal Papillary Proliferation of Brest. Actual Review and Clinicopathological Corelation
- Ovulatory Mucus and his pH, Arborization and Spermagglutination Antibodies in Women with Fertility Disorders
- Importance of Diagnostics and Therapy of Female Subvesical Obstruction in Clinical Practice